Onsite Guide - Pri-Med

Transcription

Onsite Guide
PRI-MED SOUTH
Greater Fort Lauderdale
Broward County Convention Center
February 5
Primary Care Updates
February 6–8
Annual Conference
Curriculum is developed by Pri-Med and its Medical
Education Advisory Board, which includes members
from the American College of Physicians and the
University of Miami Miller School of Medicine.
Please Join Us
for a Product Theater Lunch Presentation at
Pri-Med South 2015
Saturday
February 7, 2015
12:00 pm – 12:45 pm
BROWARD COUNTY CONVENTION CENTER
Presentation Theater #3 – Exhibit Hall Floor
Fort Lauderdale, Florida
This is a promotional event. CE/CME credit
will not be available for this session.
In compliance with PhRMA guidelines,
spouses or other guests are not permitted
to attend company-sponsored programs.
This promotional educational activity is brought
to you by Salix Pharmaceuticals and is not
certified for continuing medical education.
The speakers are presenting on behalf of
Salix Pharmaceuticals and must present
information in compliance with FDA requirements
applicable to Salix Pharmaceuticals.
If you are licensed in any state or other
jurisdiction (eg, VT, Wash. DC, ME, MN) or are
an employee or contractor of any organization
or governmental entity that limits or prohibits
meals from pharmaceutical companies, please
identify yourself so that you (and we) are able
to comply with such requirements. Your name,
the value, and the purpose of any educational
item, meal, or other items of value you receive
may be reported as required by state or federal
law. Once reported, this information may be
publicly accessible.
Thank you for your cooperation.
Indication
XIFAXAN® (rifaximin) 550 mg tablets are indicated for
reduction in risk of overt hepatic encephalopathy (HE)
recurrence in patients ≥ 18 years of age.
Important Safety Information about XIFAXAN 550 mg
XIFAXAN® (rifaximin) 550 mg tablets are contraindicated
in patients with a hypersensitivity to rifaximin, any of the
rifamycin antimicrobial agents, or any of the components
in XIFAXAN. Hypersensitivity reactions have included
exfoliative dermatitis, angioneurotic edema, and anaphylaxis.
Clostridium difficile-associated diarrhea (CDAD) has
been reported with use of nearly all antibacterial agents,
including XIFAXAN, and may range in severity from mild
diarrhea to fatal colitis. Treatment with antibacterial agents
alters the normal flora of the colon which may lead to
overgrowth of C. difficile. If CDAD is suspected or
confirmed, ongoing antibiotic use not directed against
C. difficile may need to be discontinued.
There is increased systemic exposure in patients with more
severe hepatic dysfunction. The clinical trials were limited
to patients with MELD scores < 25. Therefore, caution
should be exercised when administering XIFAXAN to
patients with severe hepatic impairment (Child-Pugh C).
Concomitant administration of drugs that are
P-glycoprotein (P-gp) inhibitors with XIFAXAN can
substantially increase the systemic exposure to XIFAXAN.
Caution should be exercised when concomitant use of
XIFAXAN and a P-gp inhibitor such as cyclosporine is
needed. In patients with hepatic impairment, a potential
additive effect of reduced metabolism and concomitant
P-gp inhibitors may further increase the systemic exposure
to XIFAXAN.
Based on animal data, XIFAXAN may cause fetal harm.
Discontinue in nursing mothers after taking into account
the importance of the drug to the mother.
The most common adverse reactions occurring in ≥ 10%
of patients and at a higher incidence than placebo in
the clinical study were peripheral edema (15%),
nausea (14%), dizziness (13%), fatigue (12%), and
ascites (11%).
Xifaxan 550 mg is licensed by Alfa Wassermann S.p.A.
to Salix Pharmaceuticals, Inc.
Please see complete Prescribing Information for
XIFAXAN at Salix booth #1024.
Presented by
© 2015 Salix Pharmaceuticals, Inc.
January 2015
XIFH-US-0037
Table of Contents
General Conference Information . . . . . . . . . . . . . . . 4-5
Primary Care Updates Sessions . . . . . . . . . . . . . . . . . 6
Annual Conference Session Schedule . . . . . . . . . . . . 8-12
Featured Sessions . . . . . . . . . . . . . . . . . . . . . . . . . 14
Continuing Medical Education Information . . . . . . . . 16-17
Primary Care Updates Session Information . . . . . . . . 18-19
Annual Conference Session Information . . . . . . . . . .19-23
Speaking Faculty for Primary Care Updates
and Annual Conference . . . . . . . . . . . . . . . . . . . 24-25
Financial Disclosures . . . . . . . . . . . . . . . . . . . . . .26-27
Exhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . .28-31
Maps of the Convention Center . . . . . . . . . . . . . . .32-34
Hours of Operation
Registration: Hall A, Level 1
Thursday, February 5 6:45am–3:30pm
Friday, February 6
6:45am–4:30pm
Saturday, February 7 6:45am–4:30pm
Sunday, February 8
6:45am–12 noon
SYLLABUS: WWW.PRI-MED.COM/SOUTH/SYLLABUS
Exhibit Hall
Friday, February 68:30am–4pm
Saturday, February 78:30am–4pm
Sunday, February 88:30am–2pm
PRI-MED SOUTH
3
GENERAL CONFERENCE INFORMATION
Badge Correction/Lost Badges
Annual Conference Syllabus
The session slides presented at Pri-Med South are available
online at www.pri-med.com/south/syllabus for eight weeks
following the conference.
Attendee Badge
As a Pri-Med attendee, you will receive a badge programmed
with your name, address, and profession. Please scan your QR
Code once per day at the Xpress Registration Counters (Hall A,
Level 1) and at the entrances to some stand-alone CME activities
to be eligible to obtain CME credit or nursing contact hours.
Scanning your QR code at an exhibit booth or a non-CME activity
gives the sponsor permission to use your contact information for
future correspondence.
NEW PROCESS for Evaluation and Claiming
Education Credit
Pri-Med’s credit award procedure has changed. Please follow
these instructions for evaluating and claiming continuing
education credit for sessions you attend at this Pri-Med
meeting:
1. Scan your badge once each day at the Xpress
Registration Counters (Hall A, Level 1) to activate your
identification for credit award.
2. Go to www.pri-med.com/south/eval to access the
online credit system, using any computer or Internetinteractive device, to complete the evaluation and
credit request process. You have 7 days to complete
this process – until Sunday, February 15, 2015.
Pri-Med staff can assist you with the process if you
have questions, and computers are available in the
registration area:
A. Enter your badge number and email address for
identification.
B. To evaluate each session, select the day and then the
session title, and complete the evaluation.
C. When you have evaluated the sessions you attended,
evaluate the overall activity.
D. Confirm credit award and attest to correct total.
Designate the type of credit you seek.
3. Receive your credit. View and print your certificate right
from the evaluation website. Your certificate will also be
posted to your Pri-Med.com account the next day.
4
PRI-MED SOUTH
If you have lost your badge or the badge has been prepared
incorrectly, please go to the Pri-Med Registration Counter located
on Level 1 in Hall A, where a new badge will be prepared.
Lost and Found
Any lost and found items can be delivered or picked up at the
Information Booth located on Level 1 in the Main Lobby.
Management Office
The Management Office is located in Room 207 on Level 2. You
are invited to visit us in this office anytime you feel that we can
be of assistance to you.
Mandatory Security Precautions
Due to security precautions in the Port of Ft. Lauderdale, ALL
attendees and exhibitors are required to have a governmentissued picture ID on their person at all times (driver’s license or
passport). Security checkpoints have been constructed at all
major entries into the port, and you will be required to show your
identification to enter.
Parking Information:
Port Everglades Garage/Northport Garage
• Price: MAX of $15.00 per day/entry. There are no in and
out privileges. Payment must be made upon exit with
the ticket.
• Location: At the entrance to the Convention Center. The
Convention Center is connected to the parking garage
through two glass-enclosed skywalks. Open 24 hours.
Northeast Lot
• Price: $6 per day
• Location: The Northeast lot is a paved lot located at the NE
corner of the fountain.
Eisenhower North and South
• Location: The Eisenhower lots are located in the back of
the Convention Center on Eisenhower Boulevard. The
entrance to these lots is before the security checkpoint.
Sails Lot
• Location: The Sails Lot is located at the corner of SE 23rd &
SE 17th St. across from the Hyatt Pier 66. The entrance is off
of SE 23rd.
Questions?
We’re here to help! Please visit the Information Booth located on
Level 1 in the Main Lobby or the Pri-Med Booth, #915, or find any
Pri-Med staff member for assistance.
GENERAL CONFERENCE INFORMATION
Spouse/Children Attendance
Spouses and/or significant others of registered professional
attendees may attend the Pri-Med Exhibit Hall when
accompanied by a professional attendee. These individuals
should go to the Registration Counter and register for a
guest badge for $35. We regret that because of space
limitations we cannot accommodate guest registrants
in the conference sessions.
So that we can provide all Pri-Med attendees with optimal
learning environments, children under the age of 16 years
are not permitted in the Exhibit Hall or the session rooms.
Complimentary Wi-Fi
Complimentary Wi-Fi is sponsored
by Janssen Pharmaceuticals, Inc.
Network Name: Janssen Diabetes Solutions
Password: Booth#215
Notice: Physician Payment Sunshine Act
In adherence to federal regulations, physicians are advised
that your information, including your name and the value
and purpose of any meal, beverage, educational item, or
other items of value you receive from a pharmaceutical
company, medical device manufacturer, or group purchasing
organization may be reported by these organizations for
public disclosure.
If you have questions or are unsure whether an item you wish
to accept is reportable, please ask a company representative at
the booth or location visited for more information.
For the full Physician Payment Sunshine Act policy, visit
www.CMS.gov under Regulations and Guidance, National
Physician Payment Transparency Program (Open Payments).
2016 PRI-MED SOUTH
REGISTRATION
Register for next year’s Annual Conference for just $40.
The conference is February 4-7, 2016 in Fort Lauderdale, FL.
Follow the orange footsteps in the Exhibit Hall to the PriMed Booth #915 or visit Registration in Hall A. You will also
have the opportunity to purchase a Fitbit activity tracker
at a preferred rate during registration and participate in
our Steps to Success community.
Fitbit activity trackers
are limited in
availability.
TICKETING
Preconference Online Ticketing Process: You spoke
and we listened. Based on past attendee feedback, we
made some improvements to our ticketing policy—
you were able to choose your Ticketed Events online
before the conference even started and forgo
standing in the Ticket Booth line!
• Ticket Distribution: the Ticketed Events which
you preregistered for will print out with your
conference badge so you’ll only have one stop
for checking-in.
• Stand-by Lines: if you were unable to
register for Ticketed Events of which you
wanted to attend, non-ticket holder
lines are available for the Ticketed
Events and we will accommodate
as many clinicians as possible.
PRI-MED SOUTH
5
PRIMARY CARE UPDATES SESSIONS
THURSDAY, FEBRUARY 5, 2015
Track 1
7:45–9am
Track 2
Session 1: Getting Your Patients to
Weigh In: Discussing Approaches to
Treating Obesity in the Primary Care
Setting
Session 1: Migraine Headaches:
Tools for Successful Management
M. Susan Burke, MD, FACP
Grand Ballroom A, Level 3
Victoria A. Catenacci, MD
Donna H. Ryan, MD
Scott Urquhart, PA-C
Floridian Ballroom, Level 3
Morning Break
9–9:15am
9:15–10:30am
Session 2: Optimizing the Diagnosis,
Treatment, and Management of
Irritable Bowel Syndrome
Brian E. Lacy, MD, PhD
Brooks D. Cash, MD, AGAF, FACG,FACP, FASGE
Session 2: A Focus on Bipolar
Depression: Overcoming Diagnostic
Barriers and Optimizing Long-Term
Patient Outcomes
Joseph R. Calabrese, MD
William Clay Jackson, MD
10:30–11:45am
Session 3: Immunization Update
Session 3: Evolving Issues and New
Treatment Approaches to Psoriasis:
What the PCP Needs to Know
John Russell, MD
Lunch Break
11:45am–12:30pm
12:30–1:45pm
Session 4: Meeting The Challenge of
Managing Lipids Beyond LDL-C
Michael Miller, MD, FACC, FAHA
Laurence Sperling, MD, FACC, FACP, FAHA
Jessica Castle, MD
Afternoon Break
1:45–2pm
2–3:15pm
Session 4: Evolving Insulin Therapy:
Optimizing Care Through Proper
Selection & Use
Session 5: One Size Fits All: The
Benefits of Exercise
Session 5: Screening Seniors: the Good,
the Bad and the Questionable
Neil Skolnik, MD
Katherine Galluzzi, DO, CMD, FACOFP dist.
There are no session restrictions for Primary Care Updates—you may attend any sessions you want on
Thursday, February 5 and any of the core CME curriculum sessions for the remainder of the conference.
6
PRI-MED SOUTH
REGISTER
REGISTER FOR NEX T YEAR’S
ANNUAL CONFERENCE FOR JUST $40.
PRI-MED SOUTH
FEBRUARY 4–7, 2016
FOR T LAUDERDALE, FL
Follow the orange footsteps in the
Exhibit Hall to the Pri-Med Booth #915
or visit Registration in Hall A.
ANNUAL CONFERENCE AGENDA
FRIDAY, FEBRUARY 6, 2015
7:45–8:45am
KEYNOTE: Power Foods for the Brain
Neal Barnard, MD
Hall D, Level 1
NETWORKING BREAK AND ADDITIONAL OPPORTUNITIES
8:45–9:45am
8:55–9:40am
The Diagnosis
and Management
of Male
Hypogonadism
Presentation by
Daiichi Sankyo, Inc.
Brought to you by
AbbVie
Exhibit Hall,
Theater 2
Brought to you by
Daiichi Sankyo, Inc.
Exhibit Hall,
Theater 1
Improving Glycemic
Control: An SGLT2
Inhibitor for the
Treatment of
Adults with Type 2
Diabetes
Understanding
High Triglycerides
Brought to you
by AstraZeneca
Pharmaceuticals LP
Room 305, Theater 4
Brought to you by
Boehringer Ingelheim
Pharmaceuticals, Inc.
Exhibit Hall, Theater 3
9:45–10:30am
Hypertension
Management:
A Moving Target
Testosterone Therapy:
Examining the Evidence
Tobias Köhler, MD, MPH, FACS
Karol Watson, MD, PhD, FACC Floridian Ballroom, Level 3
Jeffrey Brosco, MD, PhD
Update on the
Pathogenesis of
the Acute Coronary
Syndromes
Morbidity and
Complications of Childhood
Obesity
Hall D, Level 1
10:30–11:15am
Pediatric Obesity: A
Practitioner’s Guide to
a Community Problem
The Prostate: BPH
and Beyond
Mohit Khera, MD, MBA, MPH
Janine Sanchez, MD
Peter Libby, MD, FACC
Hall D, Level 1
11:15–11:30am
Cardiovascular Panel
Discussion
Men’s Health Panel
Discussion
Mohit Khera, MBA, MD, MPH
Karol Watson, MD, PhD, FACC Tobias Köhler, MD, MPH, FACS
Hall D, Level 1
Janine Sanchez, MD
LUNCH BREAK AND ADDITIONAL OPPORTUNITIES
11:30am–1pm
11:40am–
12:55pm
Pediatric Panel Discussion
Educational Symposium for Cardiologists: Latest Advances in Secondary Prevention
of Cardiovascular Events
Support for this educational symposium is provided by Merck & Co., Inc.
Grand Ballroom H, Level 3
Ticket required for entry. This session is designed for cardiologists currently engaged in patient care
and physicians who practice primarily in the management of adult patients with cardiovascular diseases.
8
PRI-MED SOUTH
12–12:45pm
Addressing Chronic
Weight Management
With Targeted
Pharmacotherapy
Understanding the Data on EPI
Brought to you by AbbVie
Brought to you by
AstraZeneca Diabetes
Brought to you by Eisai Inc.
1–1:45pm
1:45–2:15pm
2:15–3pm
* Current Concepts in the
Management of ASCVD.
What New Prevention
Evidence Tells Us
The Effect of a OnceWeekly Therapy on A1C
and Weight Over 3 Years
* SAFE Opioid Prescribing:
Evaluation in Management
and the Best Practices for
Therapy with ER/LA Opioids
Update from The Medical
Literature
Frank Domino, MD
Charles Argoff, MD, FABPM
James A. Underberg, MD, MS, Bill H. McCarberg, MD, FABPM
FACPM, FACP, FASH, FNLA
Healthy Lifestyle Options
Hall D, Level 1
Advances and Options
* SAFE Opioid Prescribing: Evidencein Female Contraception Based Tools for Screening for
Patients at Risk and Monitoring
Pelin Batur, MD, FACP,
for Adherence to Prescribed ER/LA
NCMP, CCD
Opioids
Hall D, Level 1
Approach to
Inflammatory
Bowel Disease
Frank Domino, MD
Maria Abreu, MD
Bill H. McCarberg, MD, FABPM
3–4pm
3:10–3:55pm
Emerging Trends in Alzheimer’s Disease
Management: NAMENDA XR® - A Treatment
Option for Moderate to Severe Patients
Medical Mystery: A Case of Unexplained
Recurrent Abdominal Pain
Brought to you by Forest Laboratories, Inc. an
affiliate of Actavis, Inc.
Brought to you by Shire
4–5pm
Spotlight on Hepatitis C
Infection
Michael P. Curry, MD
Hall D, Level 1
* SAFE Opioid Prescribing: Proven
Methods to Counsel Your Patients
on ER/LA Opioids and Everything
You Want to Know About ER/LAOpioids as a Drug Class
Is it Child Abuse? What the
Primary Care Practitioner
Should Know
Walter Lambert, MD
Michael Brennan, MD, FACP, FASAM
5–6pm
Update on Celiac Disease * SAFE Opioid Prescribing:
and Other Gluten-Related Getting the Most Clinical
Insights from Specific ER/LA
Disorders
Product Information Sources
Ciaran Kelly, MD
Hall D, Level 1
Common Ethical/
Legal Dilemmas in
Primary Care
Panagiota Caralis, MD,
JD, FACP
Pri-Med South Core CME Curriculum
*Partial Industry Support details, see page 16.
Non-CME session
supported by industry
Education Symposium
PRI-MED SOUTH
9
SATURDAY, FEBRUARY 7, 2015
7:45–8:45am
KEYNOTE: The Power of Lifestyle Changes, Social Networks, & Trust
Dean Ornish, MD
Hall D, Level 1
8:45–9:45am
8:55–9:40am
A Paradigm Shift In The
Treatment of Thrombosis
Brought to you by Janssen
Pneumococcal Pneumonia
and Invasive Disease
in Adults: Help Protect
Patients Aged 65+ in Your
Practice
Supporting Nurse
Practitioners and Physician
Assistants in Diabetes Care:
Targeting the Kidney in Type
2 Diabetes
Brought to you by Pfizer, Inc.
Brought to you by Janssen
Room 305, Theater 4
9:45–10:45am
Managing Heart Failure
In The PCP Setting
A Tale of Two Brains
Akshay S. Desai, MD, MPH
Salvatore Mangione, MD
Hall D, Level 1
Clinical Practice Guidelines
for the Management of
Thyroid Disorders
Gregory Brent, MD
10:45–11:45am
Practical Considerations
for Anticoagulation for
Prevention of Venous
Thromboembolism and
Stroke Due to Atrial
Fibrillation
New Approaches to
Treating C difficile
Infection
Pituitary and Adrenal
Dysfunction: How to Screen
and Manage
Kalpana Gupta, MD, MPH
James Hennessey, MD, FACP
Christian Ruff, MD, MPH
Hall D, Level 1
11:45am–1pm
12–12:45pm
Advancing
Paradigm Changes
in Type 2 Diabetes
Management
Breaking Through the
Frustration of Major
Depressive Disorder
[MDD]: Understanding
the Disease and
Brought to you
Improving Treatment
by Janssen
Pharmaceuticals, Inc. Outcomes
Exhibit Hall,
Theater 1
Brought to you by Otsuka
America Pharmaceutical,
Inc. and Lundbeck
10
PRI-MED SOUTH
Hepatic
Encephalopathy:
Understanding
the CNS
Dysfunction as a
Result of Cirrhosis
Brought to
you by Salix
Pharmaceuticals, Ltd.
Exhibit Hall,
Theater 3
Understanding
Dupuytren’s
Contracture:
Disease
Awareness for
the General
Practitioner
Brought to you
by Auxilium
Room 305, Theater 4
Virtual Clinical Coffee
Break: Observational
Medicine Through Art
1–1:30pm
Hall D, Level 1
Break: When Asthma Does
Not Get Better: Exploring
Options for Difficult to
Control Asthma
Break: Practical Tips for
Management of ADHD
Thomas Cummins, MD
Christopher Fanta, MD
Ebola Update
1:30–2pm
Hall D, Level 1
Antimicrobial Resistance
in the Community
2–2:45pm
Gio Baracco, MD, FACP
Hall D, Level 1
Bruce W. Bode, MD, FACE
Lawrence Blonde, MD,
FACP, FACE
Walking the Line: A
Primer on Gait Analysis
Screening In Women
Erin Marcus, MD, MPH
2:45–3:45pm
2:55–3:40pm
* Optimizing Insulin
Therapy for Patients
with Type 2 Diabetes:
Existing Challenges and
New Opportunities for
Improved Care
Therapeutic Benefits of Bronchodilator
Rethink HCV
Maintenance Therapy in Patients With COPD Brought to you by Gilead Sciences, Inc.
Brought to you by Boehringer Ingelheim
3:45–4:45pm
Burning Issues in GERD
Prateek Sharma, MD,
FACG, FACP
Hall D, Level 1
Strategies for Optimizing
The Skinny on Bariatric
Dementia Care for Patients Surgery: From Pre-op
and Caregivers
Evaluation to Long Term
Post-op Complications
Elizabeth Crocco, MD
Nestor de la Cruz-Munoz,
MD, FACS
4:45–5:30pm
Substance Abuse: Making Practical Assessment of
an Impact on Patient
Fall Risk in the Elderly
Outcomes
Willy Valencia, MD
D. Jeffrey Newport, MD,
MDiv, MS
A New Era in Idiopathic
Pulmonary Fibrosis
Marilyn Glassberg, MD
Hall D, Level 1
Pri-Med South Core CME Curriculum
*Partial Industry Support details, see page 16.
Non-CME session supported by industry
PRI-MED SOUTH
11
SUNDAY, FEBRUARY 8, 2015
KEYNOTE: Dharma Happiness and Purpose
7:45–8:45am
Sanjiv Chopra, MD, MACP
Hall D, Level 1
8:45–9:45am
Treatment of Deep Vein Thrombosis
(DVT) and Pulmonary Embolism (PE) and
Reducing the Risk of Recurrent DVT and PE
Following Initial Therapy
8:55–9:40am
Brought to you by Bristol-Myers Squibb and
Pfizer, Inc.
SGLT2 Inhibition: A Glucuretic
Treatment Option for Your Adult
Patients with Type 2 Diabetes
Brought to you by AstraZeneca
Pharmaceuticals, LP
Hot Topics in Dermatology
9:45–10:45am
Preventive Medicine that Works:
Adult Immunization
Daniela Kroshinsky, MD
Hall D, Level 1
Robert Hopkins, MD, FACP, FAAP
10:45–11:30am
Diagnostic Challenges of Rheumatologic
Disease
Cultural Competency in
Diagnosing Patients
Peng Fan, MD, FACP
Olveen Carrasquillo, MD , MPH
Hall D, Level 1
11:30am–12:45pm
11:40am–
12:25pm
The Prevalence of Dyslipidemia in
Diabetes: Cholesterol Management and the
Role of PCSK9 in Cholesterol Homeostasis
Pneumococcal Disease in Adults:
Key Considerations for Your Office,
Hospital, or Pharmacy
Brought to you by Amgen, Inc.
Brought to you by Merck & Co., Inc.
Controversies in Osteoporosis Prevention
and Management
*Domestic Violence
Carolyn Crandall, MD, MS
Evaluating the Evidence for Hormone
Therapy in Menopausal Women
*Update in HIV
Ki Park, MD
12:45–1:30pm
Panagiota Caralis, MD, JD, FACP
1:30–2:30pm
Gordon Dickinson, MD
* These sessions meet the criteria of the Florida Board of Registration in Medicine for 1 credit of Domestic Violence and 1 credit of HIV.
Please check your individual state licensing board requirements before claiming Domestic Violence or HIV credit.
Pri-Med South
Core CME Curriculum
12
PRI-MED SOUTH
Non-CME session
Pri-Med’s credit award procedure
has changed. Please follow these
instructions for evaluating and
requesting continuing education
credit for sessions you attend at
this Pri-Med meeting:
1. Scan your badge once each day at the appropriate
stations to activate your identification for credit award.
2. Go to www.pri-med.com/south/eval to access
the online credit system, using any computer or
Internet-interactive device, to complete the
evaluation and credit request process. You have
seven days to complete the process—until Sunday,
February 15, 2015. Pri-Med staff can assist you with
the process if you have questions and computers are
available in the registration area:
a.
Enter your badge number and email address
for identification.
b.
To evaluate each session, select the day, then the
session title, and complete the evaluation. When
you have evaluated the sessions you attended,
then evaluate the overall activity.
c.
Confirm total credit award and attest to correct
total. Designate the type of credit you seek.
3. Receive your credit. View and print your certificate
right from the evaluation Web site. Your certificate
will also be posted to your Pri-Med.com account the
next day.
FEATURED SESSIONS
Featured CME Sessions
Keynote Addresses
FRIDAY, FEBRUARY 6
SATURDAY, FEBRUARY 7
SUNDAY, FEBRUARY 8
7:45–8:45am
7:45–8:45am
7:45–8:45am
Power Foods for the Brain
The Power of Lifestyle Changes,
Social Networks & Trust
Dharma Happiness and Purpose
Neal Barnard, MD
Adjunct Associate Professor of Medicine,
George Washington School of Medicine,
Washington, DC
Dean Ornish, MD
Founder and President,
Preventive Medicine Research Institute
Clinical Professor of Medicine,
University of California Cardiff, CA
Professor of Medicine,
Harvard Medical School, Boston, MA
Senior Consultant in Hepatology,
Beth Israel Deaconess Medical Center,
Boston, MA
FRIDAY, FEBRUARY 6
1–6pm
SAFE Opioid Prescribing
Strategies. Assessment. Fundamentals. Education.
Charles Argoff, MD, FABPM; Michael Brennan, MD;
Approximately 100 million adults, representing 33% of the
population, suffer daily with chronic pain. There are many
approaches to managing this diagnosis, and ER/LA opioids are
among the most commonly used medications. While they are
effective pain relievers, there are a number of risks that must
be taken into consideration when prescribing these opioids.
Attend all SAFE Opioid Prescribing sessions and join
a Meet and Greet with the faculty, featured book
signing “Defeat Chronic Pain Now!” with co-author
Dr. Charles Argoff. *Books are on a first come first serve basis.
This educational activity is supported by an independent
educational grant from the ER/LA Opioid Analgesic REMS
Program Companies (RPC). Please see www.er-la-opioidREMS.
com for a listing of the member companies. This activity
is fully compliant with the ER/LA Opioid Analgesics REMS
education requirements issued by the U.S. Food & Drug
Administration (FDA).
14
PRI-MED SOUTH
FEATURED ACTIVITIES
Case Challenge: Management of
Shift Work Disorder - Christina, 46
The Role of Opioids in Multimodal Treatment
Approaches to Acute Pain
•
•
•
•
Multimedia/Patient Case Study
Up to 0.50 credits*
Rare Cases in Angioedema: Lifting the
Veil on a Potentially Fatal Disease
•
•
Multimedia/Webcast
Up to 1.25 credits*
Text-based
Up to 0.50 credits*
62-year old male with dyspnea on exertion
•
•
Text-based
Up to 0.50 credits*
Current Perspectives and Emerging
Approaches in Lipid Management
Beyond Digestion: The Role of Fiber in
Cardiometabolic Health
•
•
•
•
Multimedia/Webcast
Up to 1.50 credits*
Text-based
Up to 1.00 credit*
*pmiCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. pmiCME designates these
enduing activities for the above listed AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in each activity.
pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. The
above activities were planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards. These activities have been approved for the above
listed contact hours. Please see activity CME information for full information on credit designation and instructions.
**Pri-Med Qlikview database, July 2014
Provided by pmiCME
CONTINUING MEDICAL EDUCATION INFORMATION
February 5, 2015
Primary Care Updates is provided by pmiCME, the accredited
division of Pri-Med.
Target Audience
This activity is intended for clinicians in primary care, family
medicine, pediatrics, and internal medicine.
Learning Objectives*
Following participation in this activity, you should be able to:
• Evaluate new guidelines and evidence-based practices
and therapies • Enhance your ability to diagnose, treat, and manage
health problems you see in your practice
• Implement current best practices to encourage
the adoption of health promoting behaviors, avoid
unnecessary subspecialty consults, and improve your
patients’ quality of life
• Commit to specific personal practice improvements
*See session information for topic-specific learning objectives
Commercial Support
Pri-Med South Annual Conference
February 6–8, 2015
Pri-Med South Annual Conference is provided by pmiCME, the
accredited division of Pri-Med.
The curriculum is developed by Pri-Med and its Medical
Education Advisory Board, which includes members from the
American College of Physicians, Baylor School of Medicine,
David Geffen School of Medicine at UCLA, Harvard University
School of Medicine, Northwestern University Feinberg School
of Medicine, University of Massachusetts School of Medicine,
and University of Miami Miller School of Medicine.
Target Audience
This activity is intended for clinicians in primary care, family
medicine, pediatrics, and internal medicine.
Learning Objectives*
Following participation in this activity you should be able to:
• Evaluate new guidelines and evidence-based practices
and therapies
• Enhance your ability to diagnose, treat, and manage
health problems you see in your practice
• Implement current best practices to encourage the
adoption of health-promoting behaviors, avoid
unnecessary subspecialty consults, and improve your
patients’ quality of life
Primary Care Updates is supported by educational grants
from Amarin Pharma Inc.; Forest Laboratories Inc.;
Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.;
sanofi-aventis U.S. and Sunovion Pharmaceuticals Inc.
*See session information for topic-specific learning objectives
Faculty Credentials and Financial Disclosures
Commercial Support
Please see pages 24–28 for financial disclosure information
for faculty and other content contributors.
Accreditation and Credit Designation
• AMA PRA Designation Statement
pmiCME designates this live activity for a maximum of
6.25 AMA PRA Category 1 credits™. Physicians should
claim only the credit commensurate with the extent of
their participation in the activity.
• American Academy of Family Physicians
This live activity, Primary Care Updates from 2/5/15 to
2/5/15, has been reviewed and is acceptable for up to
6.25 prescribed credit(s) by the American Academy
of Family Physicians (AAFP).
• American Association of Nurse Practitioners
pmiCME is approved as a provider of nurse practitioner
continuing education by the American Association of
Nurse Practitioners. AANP provider 040308. This program
has been approved for 6.25 contact hours of continuing
education (which includes 3.25 hours of pharmacology).
16
PRI-MED SOUTH ANNUAL CONFERENCE
• Commit to specific personal practice improvements
The Annual Conference is partially supported by a grant
from Merck & Co., Inc.; sanofi-aventis U.S.; and the SAFE
Opioid Prescribing educational activity is supported by
an independent educational grant from the ER/LA Opioid
Analgesic REMS Program Companies (RPC). Please see
www.er-la-opioidREMS.com for a listing of the member
companies. This activity is fully compliant with the ER/LA
Opioid Analgesics REMS education requirements issued by
the U.S. Food & Drug Administration (FDA).
Faculty and Financial Disclosures
See pages 24–28 for a full list of program faculty and financial
disclosure information.
Accreditation and Credit Designation
• ACCME Accreditation Statement
pmiCME is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing
medical education for physicians.
CONTINUING MEDICAL EDUCATION INFORMATION
• AMA PRA Designation Statement
pmiCME designates this live activity for a maximum of
17.75 AMA PRA Category 1 credits™. Physicians should
claim only the credit commensurate with the extent of
their participation in the activity.
• American Academy of Family Physicians
This live activity, Pri-Med South Annual Conference from
2/6/15 to 2/8/15, has been reviewed and is acceptable for
up to 17.75 prescribed credit(s) by the American Academy
of Family Physicians (AAFP).
• American Association of Nurse Practitioners
pmiCME is approved as a provider of nurse practitioner
continuing education by the American Association of
Nurse Practitioners. AANP provider 040308. This program
has been approved for 17.75 contact hours of continuing
education (which includes 9 hours of pharmacology).
Day 1
SESSION
AMA PRA Category
1 Credits™ or
AANP Contact
Hours (AANP
Pharmacology)
CUMULATIVE
AMA PRA Category
1 Credits™ or
AANP Contact
Hours (AANP
Pharmacology)
Morning Sessions
3 (1.5)
3 (1.5)
Afternoon Sessions
3.75 (2)
6.75 (3.5)
3 (1.5)
9.75 (5)
3.5 (1.75)
13.25 (7)
2.75 (1.5)
16 (8)
1.75 (1)
17.75 (9)
Day 2
Morning Sessions
Afternoon Sessions
Day 3
Morning Sessions
Afternoon Sessions
About pmiCME
Pri-Med programs are owned and operated by DBC Pri-Med,
LLC, a division of Diversified Communications, located in Boston,
Massachusetts. The accredited provider for this program is
pmiCME, the accredited division of Pri-Med.
Accredited with Commendation by the ACCME and approved
as a provider of continuing education by the AANP, pmiCME
ensures that Pri-Med continuing education programs are
high-quality, credited learning experiences for participants,
faculty speakers, and supporters alike. pmiCME provides
conferences, an online learning platform, and innovative
forms of distance education in order to contribute to the
continuing professional development of health care providers
and to influence clinical practice behaviors for the purpose of
improving health outcomes.
Academic Partnerships
pmiCME and the American College of Physicians (ACP)
gratefully acknowledge the University of Miami Miller School of
Medicine and Tufts Health Care Institute as academic partners
providing independent expert reviews of Annual Conference
educational content.
Disclosure and Conflict of Interest
Resolution Policy
pmiCME requires all individuals in a position to influence
educational content for pmiCME-certified CME activities
to disclose relevant personal financial relationship(s) with
commercial interests prior to contributing to the activity.
pmiCME assesses disclosed relationships and follows a defined
process to resolve real or implied conflicts to ensure, to the best
of our ability, that all educational content is free of commercial
bias. Financial disclosures are listed in this guidebook and will
also be announced prior to the start of each presentation and
posted on www.pri-med.com.
Discussion of Off-Label Uses and
Investigational Products
During the course of their presentations, the faculty may
mention uses of products that have not been approved in
the United States for the indication(s) being discussed. All
presenters are instructed to notify participants when they
are discussing unapproved uses or investigational agents. In
addition, specific slides will include notation of the off-label
use or investigational agent being discussed. Views presented
during this program related to unapproved uses of products
are solely those of the presenter(s) and are not endorsed by
pmiCME or DBC Pri-Med, LLC.
Disclaimer
No part of this program syllabus may be reproduced or
otherwise incorporated into any information retrieval system
without the written permission of DBC Pri-Med, LLC. The
opinions, recommendations, and perspectives expressed in
the syllabus and accompanying presentations are those of
the faculty only and do not necessarily reflect the opinions,
recommendations, or perspectives of their affiliated institutions,
pmiCME, Diversified Communications, or commercial
supporters. Clinical judgment must guide each clinician in
weighing the benefit of any intervention or treatment against
the risk of the intervention or treatment. Dosage, indications,
and methods of use for products referred to in this program are
not necessarily the same as indicated in the package insert for
the product and may reflect the clinical experience or expertise
of the faculty speaker. No procedures or treatments should
be utilized without evaluation of the patients’ conditions and/
or possible contraindications or risks and without a review of
any applicable product information and comparison with the
recommendations of other authorities.
PRI-MED SOUTH
17
SESSION INFORMATION
Session 4 – Meeting the Challenge of Managing Lipids
Beyond LDL-C
Education Partner: Medtelligence, LLC
Thursday, February 5, 2015
FLORIDIAN BALLROOM, LEVEL 3
Session 1 – Getting Your Patients to Weigh In:
Discussing Approaches to Treating Obesity
in the Primary Care Setting
Donna H. Ryan, MD
Education Partner: Institute for Medical and Nursing Education
• Summarize current recommendations for screening, assessment,
and treatment goals in the management of adult obesity
• Develop individualized therapeutic regimens for adults with
obesity, incorporating lifestyle management and adjunct therapies
as appropriate, based on current treatment recommendations and
recent evidence
• Utilize clinically validated approaches and tools to engage
and support patients in the management of adult obesity as
a chronic disease
Session 2 – Optimizing the Diagnosis, Treatment,
and Management of Irritable Bowel Syndrome
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Education Partner: Miller Medical Communications, LLC
• Diagnose IBS and differentiate from other bowel disorders using
established clinical guidelines
• Summarize the efficacy and safety of pharmacologic and
nonpharmacologic treatment options for IBS
• Implement patient-specific methods for managing IBS symptoms
and improving function and quality of life
Session 3 – Immunization Update
John Russell, MD
• Describe the new guidelines from the ACIP for the use of the
conjugate pneumococcal vaccine
• Discuss changes to this year’s influenza recommendations
from the ACIP
• Review research on the use of high dose influenza vaccine
• Understand the indications for the new meningococcal
serotype B vaccine
18
PRI-MED SOUTH
• Discuss the role of elevated triglyceride (TG) levels in the assessment
and diagnosis of dyslipidemia, including cardiovascular risk factors
• Apply best practices in the attainment of TG levels, including the
role of fasting and nonfasting states in accurate evaluation
• Evaluate the management of hypertriglyceridemia through greater
adherence to evidenced based practices and accepted guidelines
• Select potential new and emerging therapeutic approaches to
manage TG-based dyslipidemia, mixed dyslipidemia, and associated
cardiovascular risk
Session 5 – One Size Fits All: The Benefits of Exercise
Neil Skolnik, MD
• Describe the increased effect of exercise on a range of diseases
including cancer, diabetes, depression and cardiovascular disease
• Discuss the relationship between exercise and mortality
• Discuss current USPSTF and American Heart Association
recommendations regarding exercise
• Describe a practical approach to discussing exercise in the office,
the “Exercise Prescription”
GRAND BALLROOM A, LEVEL 3
Session 1 – Migraine Headaches:
Tools for Successful Management
• Improve the identification of migraines in the patient with recurring
headache and disability
• Apply the latest evidence-based recommendations for preventive
and abortive migraine treatment
• Recommend complementary and alternative therapies when
indicated
Session 2 – A Focus on Bipolar Depression:
Overcoming Diagnostic Barriers and Optimizing
Long-Term Patient Outcomes
Education Partner: Integritas Communications Group
• Discuss clinically relevant pathophysiology of bipolar disorder,
including epidemiologic and mechanistic relationships with
cardiometabolic disturbances
• Identify patients with bipolar depression based on comprehensive
patient histories, risk factors, key presenting symptoms, and the
latest diagnostic criteria
• Tailor therapeutic regimens for bipolar depression to reflect
efficacy, safety, and tolerability of approved agents and common
patient comorbidities
• Engage patients with bipolar depression to motivate active
participation in ongoing care and improve treatment adherence
SESSION INFORMATION
Session 3 – Evolving Issues and New Treatment
Approaches to Psoriasis: What the PCP Needs to Know
Update on the Pathogenesis of the Acute
Coronary Syndromes
Education Partner: Vindico Medical Education, LLC
• Incorporate therapeutic strategies that manage the systemic
manifestations and comorbidities associated with psoriasis
• Assess the risk-benefit profiles of conventional and emerging
treatments for psoriasis to assist in therapeutic decision making
• Recognize the physiological and psychological impacts of psoriasis,
counsel patients accordingly, and incorporate care coordination
and active patient engagement to improve outcomes in patients
with psoriasis
• Understand current data regarding the cellular and molecular
pathogenesis of acute coronary syndromes
• Become acquainted with the scientific basis of therapeutic goal of
“plaque stabilization”
• Understand the shifts in the clinical aspects of acute coronary
syndromes in the statin era
• Discuss current and emerging therapies to prevent acute coronary
syndromes
Session 4 – Evolving Insulin Therapy: Optimizing
Care Through Proper Selection & Use
Cardiovascular Panel Discussion
Jessica Castle, MD
Education Partner: Horizon CME
• Implement strategies for the timely initiation of insulin therapy to
best achieve glycemic control in patients with type 2 diabetes
• Design insulin regimens that are appropriate and tailored to a
patient’s specific needs
• Recognize the barriers to insulin-mediated glucose control and
apply strategies to overcome them
• Outline the clinical profiles and evidence for emerging basal insulins
for the treatment of type 2 diabetes
Session 5 – Screening Seniors: the Good, the Bad
and the Questionable
Katherine Galluzzi, DO, CMD, FACOFP dist.
•
•
•
•
Review the current guidelines for screening in older individuals
Consider which guidelines are most applicable for geriatric patients
Recognize the potential for adverse consequences of overscreening
Evaluate tools for estimating life expectancy and identify a practical
method to determine stopping age for colon and breast cancer
screening
Friday, February 6, 2015
HALL D, LEVEL 1
Power Foods for the Brain
Karol Watson, MD, PhD, FACC
Current Concepts in the Management of ASCVD.
What New Prevention Evidence Tells Us
James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA
• Assess methodologies for establishing risk profiles so as to develop
individualized patient-centric approaches to care
• Understand and incorporate current evidence-based primary and
secondary preventive strategies for the management of cholesterol
and cardiovascular disease
• Discuss and apply new clinical evidence which helps to reduce
major cardiovascular events in patients who present with acute
coronary syndrome and or intolerance to statins
Advances and Options in Female Contraception
Pelin Batur, MD, FACP, NCMP, CCD
• Become familiar with the newest contraceptive options available
• Understand how a patient’s medical background affects
recommended choice of contraceptive
Spotlight on Hepatitis C Infection
• Understand epidemiology and risk factors for chronic hepatitis C
• Review natural history and clinical impact of chronic hepatitis C
infection
• Discuss current treatment options of chronic hepatitis C infection
Neal Barnard, MD
• Identify foods that increase cognitive function and boost folate,
vitamin B6, and vitamin B12
• Identify the risks of dairy and meat products to memory
• Explain the latest research on toxic metals, like aluminums found in
cookware, soda cans, and common antacids
Update on Celiac Disease and Other Gluten-Related
Disorders
Ciaran Kelly, MD
• Apply new recommendations for the diagnosis of celiac disease
and other gluten disorders
• Counsel patients on dietary adjustments as indicated
Hypertension Management: A Moving Target
• Review the JNC8 guidelines for hypertension in adults, with special
attention to new blood pressure goals
• Consider patient factors such as age, co-morbidities, and race when
prescribing anti-hypertensive therapy
PRI-MED SOUTH
19
SESSION INFORMATION
Testosterone Replacement Therapy for
Hypogonadism: What is the evidence? Is it safe?
• Review role of testosterone in men’s health
• Discuss the diagnosis of hypogonadism
• Highlight published treatment guidelines for testosterone
replacement therapy (TRT)
• Discuss the effects of TRT in general and on the prostate in the
aging male
The Prostate: BPH and Beyond
•
•
•
•
Understand how to diagnose and treat men with BPH
Be familiar with the AUA 2014 updated BPH guidelines
Understand how to diagnose and treat men with ED
Understand the relationship between ED and cardiovascular disease
Men’s Health Panel Discussion
SAFE Opioid Prescribing: Evaluation in Management
Using ER/LA Opioids and the Best Practices for
Therapy with ER/LA Opioids
• Identify risk factors for opioid-related aberrant behavior
• Differentiate between tolerance, physical dependence, and addiction
• Convert patients from immediate-release to ER/LA opioids as well
as from one ER/LA opioid to another
• Identify predisposing risk factors for significant respiratory depression
SAFE Opioid Prescribing: Evidence-Based Tools for
Screening for Patients at Risk and Monitoring for
Adherence to Prescribed ER/LA Opioids
• Evaluate and manage adverse effects of ER/LA-opioids
• Differentiate strategies for monitoring patient adherence
SAFE Opioid Prescribing: Proven Methods to Counsel
Your Patients on ER/LA Opioids and Everything You
Want to Know About ER/LA-Opioids as a Drug Class
• Implement counseling strategies to ensure patients know to take
ER/LA opioids exactly as prescribed
• Use counseling strategies to explain signs of ER/LA opioid overdose
to patients and caregivers
• Assess the differences in opioid metabolism and how these impact
appropriate ER/LA prescribing
• Identify how opioid-drug interactions influence ER/LA opioid
prescribing
20
PRI-MED SOUTH
SAFE Opioid Prescribing: Getting the Most Clinical
Insights from Specific ER/LA Product Information
Sources
• Differentiate the prescribing information among available
ER/LA opioids
• Identify ER/LA opioids and dosages indicated for opioid-tolerant
patients only
Pediatric Obesity: A Practitioner’s Guide to a
Community Problem
• Describe the epidemiology of obesity among children in the U.S.
• List behaviors that increase the risk of obesity in children
• Apply motivational interviewing techniques to recommendations
for exercise and nutrition
• Articulate a strategy for effecting community-based solutions
to obesity
Morbidity and Complications of Childhood Obesity
Janine Sanchez, MD
• Recognize endocrine morbidity issues associated with obesity in
children and adolescents
• Effectively screen for and diagnose metabolic complications of
obesity in children and adolescents
• Devise evidence-based treatment strategies for childhood
complications of obesity and refer appropriate cases to
endocrinology
Pediatric Panel Discussion
Jeffery Brosco, MD, PhD
Janine Sanchez, MD
Update from the Medical Literature
Frank Domino, MD
• Review evolving concepts that may affect one’s practice.
• Understand how the concepts of EBM can be applied to inform
patient care
• Remain skeptical of the assumptions & influences on medical
literature
Healthy Lifestyle Options
Frank Domino, MD
• Review data on common approaches for patients and providers to
help improve health
• Discuss some novel approaches to traditional treatment
interventions
• Consider advice on eating, exercise, and medication for primary
prevention
SESSION INFORMATION
Best Approach to Inflammatory Bowel Disease
Maria Abreu, MD
• Translate the concepts related to pathogenesis of inflammatory
bowel disease (IBD)
• Employ strategies for implementing first-line therapy for IBD
• Manage side effects and develop preventive care plans for IBD
patients on immunomodulatory or biologic therapy
Is it Child Abuse? What the Primary Care Practitioner
Should Know
Walter Lambert, MD
• Explain the statutory requirements for reporting reasonable
suspicion of child maltreatment
• Recognize patterned bruises and burns associated with
inflicted injuries
• Discuss the dynamics of child sexual abuse and how it differs from
an acute sexual assault (rape)
Practical Considerations for Anticoagulation for
Prevention of Venous Thromboembolism and Stroke
Due to Atrial Fibrillation
• Implement appropriate risk stratification for patients with AF
• Assess the risks and benefits of oral anticoagulation options for
stroke prevention in patients with AF
• Select and initiate an appropriate anticoagulant strategy for
patients at risk for recurrent VTE
• Identify high-risk medical patients for whom thromboprophylaxis
should be initiated
Virtual Clinical Coffee Break - Observational Medicine
Through Art
• Sharpen observational skills
• Understand the role of visual arts in fostering observation
• Rekindle the right brain mode of engagement
Common Ethical/Legal Dilemmas in Primary Care
• Understand the historical context of the relationship between
medicine and law in the US and how it has evolved over time
• Discuss common legal and ethical dilemmas physicians face,
including duty to prevent harm, disclosure, informed consent, and
right to refuse treatment
• Develop strategies for navigating potential legal pitfalls in primary
care practice in order to avoid liability, while providing the best
possible patient care
Saturday, February 7, 2015
HALL D, LEVEL 1
The Power of Lifestyle Changes, Social Networks,
& Trust
Dean Ornish, MD
• Understand successful strategies for motivating people to make
and maintain comprehensive lifestyle changes
• Describe the evidence from randomized controlled trials showing
that chronic diseases such as coronary heart disease and prostate
cancer may be stopped or even reversed by making comprehensive
lifestyle changes
• Describe the evidence showing that comprehensive lifestyle
changes may affect gene expression
Managing Heart Failure in the PCP Setting
• Discuss epidemiology and prevalence of heart failure
• Outline an approach to diagnosis and initial evaluation of heart
failure patients
• Apply evidence-based therapy to the population with heart failure
and reduced EF
• Outline a management approach to heart failure with preserved EF
(HF-PEF)
Hot Topics in Infectious Disease
• Identify epidemiological risk factors for Ebola Virus Disease
• Recognize clinical features of Ebola Virus Disease
• Employ measures for prevention of the spread of Ebola Virus Disease
Antimicrobial Resistance in the Community
• Review data on emerging antimicrobial resistant bacteria in the
outpatient practice
• Discuss the extent and clinical implications of antimicrobial
resistance in the community
• Apply strategies that promote good antibiotic stewardship in the
outpatient setting
Burning Issues in GERD
Prateek Sharma, MD, FACG, FACP
• Understand the pathophysiology and changing epidemiology
of GERD
• List the various treatment options for these patients
• Evaluate the complications and extra esophageal manifestations
of GERD
Substance Abuse: Making an Impact
on Patient Outcomes
D. Jeffrey Newport, MD, MS, MDiv
• Understand addictive illness
• Manage alcohol addiction
• Manage opioid addiction
PRI-MED SOUTH
21
SESSION INFORMATION
A Tale of Two Brains
• Explore the differences between right- and left-brain modes of
engagement
• Understand why a right-brain mode may actually be beneficial for
the clinician
New Approaches to Treating C. Difficile Infection
• Distinguish risk factors for C. Difficile Infection (CDI) in
an outpatient with recent diarrheal symptoms
• Consider the pros and cons of treatment modalities
• Employ prevention measures for clinicians, patients,
and households
Virtual Clinical Coffee Break - When Asthma
Does Not Get Better: Exploring Options for
Difficult-to-Control Asthma
• Explore potential causes of difficult-to-control asthma • Develop a systematic approach to the patient whose asthma fails
to improve with standard therapy • Consider potential therapeutic options for difficult-to-control asthma Optimizing Insulin Therapy for Patients with Type 2
Diabetes: Existing Challenges and New Opportunities
for Improved Care
Lawrence Blonde, MD, FACP, FACE
• Better identify and understand the pathophysiologic defects
contributing to postprandial hyperglycemia and its impact on
managing the glycemic burden in patients with type 2 diabetes
mellitus
• Incorporate assessment of postprandial glucose as part of
diagnostic and treatment plan so as to target therapy to better
manage hyperglycemia and prevent potential complications in
patients with type 2 diabetes mellitus
• Overcome both clinician and patient resistance to appropriate
initiation and intensification of insulin therapy to best manage
postprandial hyperglycemia, while lowering risk for adverse events
• Better distinguish conventional, new, and emerging prandial insulin
therapies for appropriate treatment selection in patients with T2DM
so as to properly integrate in to care and improve outcomes
Strategies for Optimizing Dementia Care for Patients
and Caregivers
• Understand the most common causes of dementia in the elderly,
and their unique clinical management needs
• Recognize and classify dementia symptomatology and learn when
to implement pharmacologic and non-pharmacologic treatments
• Understand the important role of the caregiver in dementia
treatment and help guide caregivers them towards the most
optimal best care they can provide
22
PRI-MED SOUTH
Practical Assessment of Fall Risk in the Elderly
Willy Valencia, MD
• Recognize the relevance of falls as a geriatric syndrome with major
implications for the older adult and the society
• Identify assessment tools for the outpatient setting to detect
patients who fall or are at risk for falls
• Implement evidence-based interventions for the management
and prevention of falls
Clinical Practice Guidelines for the Management
of Thyroid Disorders
Gregory Brent, MD
• Utilize clinical practice guidelines to diagnose and manage thyroid
nodules and thyroid cancer
• Utilize clinical practice guidelines to diagnose and manage
hypothyroidism
Pituitary and Adrenal Dysfunction: How to Screen
and Manage
James Hennessey, MD, FACP
• Recognize the clinical presentation of, diagnostic approach to,
and therapeutic interventions for adrenal insufficiency
• Be able to list the likely causes of pituitary masses
• Implement a basic but effective evaluation of pituitary function
prior to referral
Virtual Clinical Coffee Break – Practical Tips for
Management of ADHD
Thomas Cummins, MD
• Identify the core symptoms of ADHD
• Consider patient factors and the pros and cons of ADHD drugs
when selecting treatment
Walking the Line: A Primer on Gait Analysis
• Incorporate gait evaluation in determining fall risk in elderly patients
• Recognize gaits that are associated with common musculoskeletal
conditions
• Recognize gaits that are associated with common neurological
conditions
• Link gait abnormalities to historical figures and celebrities
Screening in Women
Erin Marcus, MD, MPH
• Describe the criteria used by the United States Preventive Services
Task Force in evaluating screening tests
• Apply screening recommendations for common female cancers,
such as breast and cervical cancer
The Skinny on Bariatric Surgery: From Pre-op
Evaluation to Long-term Post-op Complications
Nestor de la Cruz-Munoz, MD, FACS
• Explain the most common bariatric surgical procedures
• Understand the data showing that bariatric surgery impacts chronic
diseases and mortality
• List the common postoperative complications and how they differ
by procedure performed
SESSION INFORMATION
A New Era in Idiopathic Pulmonary Fibrosis
Marilyn Glassberg, MD
• Describe the differential diagnosis of IPF utilizing clinical features,
imaging studies, and surgical biopsy
• Implement evidence-based strategies for measuring disease
progression and treatment response
• Identify opportunities for interdisciplinary collaboration,
consultation, and referral that can facilitate early and accurate
IPF diagnosis and therapy
Sunday, February 8, 2015
HALL D, LEVEL 1
Dharma Happiness and Purpose
• Recognize that the key to sustained happiness is living with purpose
• Identify four traits of happy individuals
• Recall the “happiness formula” and be able to list the 6 “happiness
countries”
Hot Topics in Dermatology
• Correctly identify different manifestations and types of cellulitis
• Employ appropriate tests for diagnosing cellulitis and its variants
• Differentiate between cellulitis and pseudocellulitis in order to
effectively treat the condition
Diagnostic Challenges of Rheumatologic Disease
Peng Thim Fan, MD, FACP
• Recognize the importance of pathophysiology in understanding
rheumatic disease–target tissue and characteristic joint distribution
• Distinguish inflammatory from noninflammatory (degenerative)
arthritis and nonarticular (soft-tissue) rheumatic conditions
• Learn the role of laboratory and imaging studies in rheumatologic
diagnosis
• Understand the features that distinguish fibromyalgia from other
rheumatic diseases
Controversies in Osteoporosis Prevention and
Management
• Understand the guidelines and controversies regarding choice,
benefits, and adverse effects of therapy
• Understand the current controversies regarding duration of therapy
and monitoring during therapy
Evaluating the Evidence for Hormone Therapy
in Menopausal Women
Ki Park, MD
• Apply up-to-date information about the natural history of menopause
to improve the care of individual women
• Counsel women about the risks and benefits of systemic hormone
therapy for menopausal symptoms, based on their personal risk profile
• Advise women about the relative efficacy, risks, and benefits of
commonly used alternatives to systemic hormone therapy for
treatment of menopausal symptoms, including lifestyle changes;
cognitive behavioral therapy; nonhormonal pharmacotherapies; newly
FDA-approved SERM-based therapies; complementary and alternative
therapies; and topical therapies for atrophic vaginitis
Preventive Medicine that Works: Adult Immunization
Robert Hopkins, MD, FACP, FAAP
• Understand the gap between national immunization goals and
current immunization rates
• Use the current ACIP guidelines to vaccinate adult patients
• Implement strategies to improve immunization rates in your office
• Vaccinate adults at high risk for vaccine-preventable disease
Cultural Competency in Diagnosing Patients
Olveen Carrasquillo, MD, MPH
• Review the demographic, socioeconomic, cultural, and healthcare
systems factors that impact the the health of Latino patients
• Develop cultural competencies and motivational interviewing
skills to improve patient-provider communication and enhance
adherence in Latino patients
• Utilize culturally-tailored systemic strategies, including
multidisciplinary collaboration and referrals to community-based
resources, implement treatment plans and patient education in
Latino patients
Domestic Violence
• Define domestic violence and its impact on health care
• Understand the prevalence of domestic violence and current
theories related to its occurrence
• Learn how to screen and evaluate victims or perpetrators of
domestic violence
• Describe differences among adult-partner abuse, abuse of the
elderly, and human trafficking
Update in HIV
•
•
•
•
Ensure that patients are appropriately screened for HIV infection
Recognize the acute retroviral syndrome
Describe when antiretroviral therapy should be initiated
Name three factors that impact the selection of an antiretrovial
regimen
PRI-MED SOUTH
23
FACULTY CREDENTIALS FOR PRIMARY CARE UPDATES
AND PRI-MED SOUTH ANNUAL CONFERENCE
Maria Abreu, MD
Chief, Division of Gastroenterology
Martin Kalser Chair in Gastroenterology
Professor of Medicine
Professor of Microbiology and Immunology Director,
Crohn’s & Colitis Center
University of Miami Miller School of Medicine
Miami, FL
Professor of Neurology, Albany Medical Center
Director, Comprehensive Pain Program Albany
Medical Center
Albany, NY
Miami VA Healthcare System
Miami, FL
Neal Barnard, MD
Adjunct Associate Professor of Medicine
George Washington School of Medicine
Washington, DC
Education Director
Primary Care Women’s Health
Deputy Editor
Cleveland Clinic Journal of Medicine
Cleveland, OH
Director, Ochsner Diabetes Clinical Research Unit
Department of Endocrinology,
Diabetes and Metabolic Diseases
Ochsner Medical Center
New Orleans, LA
Atlanta Diabetes Associates
Clinical Associate Professor, Department of Medicine
Emory University
Atlanta, GA
Michael J. Brennan, MD, FACP, FASAM
The Pain Center of Fairfield
Fairfield, CT
Senior Attending Physician, Department of Medicine
Bridgeport Hospital
Bridgeport, CT
Gregory Brent, MD
Professor of Medicine and Physiology
David Geffen School of Medicine
University of California, Los Angeles
Los Angeles, CA
Professor of Clinical Pediatrics
Miami, FL
Associate Director, Mailman Center for Child
Development
Chair, Pediatric Bioethics Committee
Jackson Memorial Hospital
Regional Medical Director
CMS South Region (Florida’s Title V Agency)
24
PRI-MED SOUTH
Adjunct Associate Professor of Geriatrics,
Philadelphia College of Osteopathic Medicine
Associate Professor of Medicine, Thomas Jefferson
University Philadelphia, PA
Senior Advisor, Lankenau Medical Associates,
Lankenau Medical Center
Wynnewood, PA
Bipolar Disorders Research Chair
Professor, Department of Psychiatry
Director, Mood Disorders Program
University Hospitals Case Medical Center
Case Western Reserve University School of Medicine
Cleveland, OH
Miami Veterans Affairs Hospital
Chief, Division of General Internal Medicine
Division Head, Health Services Research & Policy
Miami, FL
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Professor of Medicine, University of South Alabama
Mobile, AL
Jessica Castle, MD
Assistant Professor, Oregon Health & Science University
Portland, OR
Assistant Professor of Medicine
Division of Endocrinology, Metabolism, and Diabetes
University of Colorado School of Medicine
Aurora, CO
Professor of Medicine, Harvard Medical School
Boston, MA
James Tullis Firm Chief, Department of Medicine
Beth Israel Deaconess Medical Center
Boston, MA
Professor of Medicine, David Geffen School of Medicine
at University of California, Los Angeles
Los Angeles, CA
Chief, Division of Geriatric Psychiatry
Department of Psychiatry and Behavioral Sciences
Miami, FL
Geriatric Psychiatry Training Director
Jackson Memorial Hospital
Miami, FL
Nestor de la Cruz-Munoz, MD, FACS
Associate Professor of Surgery
Chief, Division of Laparoendoscopic and Bariatric Surgery
Miami, FL
Medical Director, Liver Transplantation
Associate Professor of Medicine, Harvard Medical School
Boston, MA
Associate Physician, Advanced Heart Disease Section
Cardiovascular Division
Brigham and Women’s Hospital
Harvard Medical School
Boston, MA
Chief, Infectious Diseases Section
Miami Veteran Affairs Medical Center
Miami, FL
Frank Domino, MD
Professor and Clerkship Director
Family Medicine and Community Health
University of Massachusetts Medical School
Worcester, MA
Committee Member, Course Development
Boston, MA
Clinical Professor of Medicine
Division of Rheumatology
David Geffen School of Medicine at UCLA
Los Angeles, CA
Member, Pulmonary and Critical Care Division
Associate Professor of Medicine
Boston, MA
Katherine E. Galluzzi, DO, CMD, FACOFP dist.
Professor and Chair, Department of Geriatrics
Director, Comprehensive Care @ PCOM
Philadelphia College of Osteopathic Medicine
Philadelphia, PA
Marilyn K. Glassberg, MD
Professor of Medicine and Surgery
Director, Rare and Interstitial Lung Disease Program
Miami, FL
Jeffrey Gudin, MD
Director, Pain and Palliative Care
Englewood Hospital and Medical Center
Englewood, NJ
Boston University School of Medicine
Chief, Section of Infectious Diseases
VA Boston Healthcare System
Boston, MA
James V. Hennessey, MD, FACP
Director, Clinical Endocrinology
Division of Endocrinology
Boston, MA
Robert Hopkins, Jr., MD, FACP, FAAP
Professor of Internal Medicine and Pediatrics
University of Arkansas for Medical Sciences
College of Medicine
Little Rock, AR
FACULTY CREDENTIALS FOR PRIMARY CARE UPDATES
AND PRI-MED SOUTH ANNUAL CONFERENCE
Clinical Assistant Professor
of Psychiatry & Family Medicine
University of Tennessee College of Medicine
President & Medical Director
Comprehensive Primary Care
Medical Director, Methodist Alliance Hospice and
Palliative Services
Memphis, TN
Ciaran Kelly, MD
Professor of Medicine, Harvard Medical School
Chief, Herrman L. Blumgart Internal Medicine Firm
Medical Director of the Celiac Center
Director of Gastroenterology Training
Beth Isreal Deaconess Medical Center
Boston, MA
Associate Professor of Urology
Scott Department of Urology
Baylor College of Medicine
Houston, TX
Associate Professor & Residency Program Director
Southern Illinois University
Division of Urology
Chief, Division of Male Infertility
SIU Fertility and IVF Center
Director, Onco-Fertility Program
Simmons Cancer Institute
Springfield, IL
Assistant Professor of Dermatology
Director of Inpatient Dermatology
Massachusetts General Hospital
Boston, MA
Section Chief, Gastroenterology & Hepatology
Geisel School of Medicine at Dartmouth
Director, GI Motility Laboratory
Dartmouth-Hitchcock Medical Center
Lebanon, NH
Walter Lambert, MD
Associate Professor of Clinical Pediatrics
Medical Director, Child Protection Team
Miami, FL
Cardiovascular Medicine, Brigham and Women’s Hospital
Mallinckrodt Professor of Medicine
Boston, MA
Jefferson Medical College
Philadelphia, PA
Erin N. Marcus, MD, MPH
Associate Professor of Clinical Medicine
and Public Health
Division of General Internal Medicine
Miami, FL
Founder, Chronic Pain Program
Founder, Kaiser Permanente
San Diego, CA
Professor of Cardiovascular Medicine
Epidemiology & Public Health
University of Maryland School of Medicine
Director, Center for Preventive Cardiology
University of Maryland Medical Center
Baltimore, MD
Medical Director
Health & Recovery Jackson Behavioral Health Hospital
Director, Women’s Reproductive Mental Health
Professor of Psychiatry & Behavioral Sciences and
Obstetrics & Gynecology
Miami, FL
Dean Ornish, MD
Founder and President
Preventive Medicine Research Institute
Clinical Professor of Medicine, University of California
Cardiff, CA
Ki Park, MD
Interventional Cardiology
Division of Cardiovascular Medicine
University of Florida
Gainesville, FL
Janet Pregler, MD, FACP
Director, Iris Cantor-UCLA Women’s Health Center
Professor of Clinical Medicine
David Geffen School of Medicine
University of California, Los Angeles
Los Angeles, CA
Associate Physician, Cardiovascular Division
Boston, MA
John Russell, MD
Clinical Professor, Family and Community Medicine
Temple University School of Medicine
Philadelphia, PA
Associate Director, Family Medicine Residency Program
Abington Memorial Hospital
Abington, PA
Donna H. Ryan, MD
Professor Emerita
Pennington Biomedical Research Center
New Orleans, LA
Sammy Saab, MD, MPH, AGAF
Professor of Medicine and Surgery
Assistant Professor of Nursing
David Geffen School of Medicine at UCLA
Los Angeles, CA
Janine Sanchez, MD
Associate Professor of Pediatrics
Director, Pediatric Diabetes
Division of Pediatric Endocrinology
Miami, FL
Division of Gastroenterology and Hepatology
Director of the Fellowship Training Program
University of Kansas School of Medicine
Kansas City, MO
Neil Skolnik, MD
Professor, Family and Community Medicine,
Temple University School of Medicine
Philadelphia, PA
Associate Director, Family Medicine Residency Program
Abington Memorial Hospital
Abington, PA
Professor of Medicine (Cardiology)
Director, Emory Heart Disease Prevention Center
Emory University School of Medicine
Professor of Global Health
Hubert Department of Global Health
Rollins School of Public Health at Emory University
Atlanta, GA
James A. Underberg, MD, MS,
Lipidology & Cardiovascular Disease Prevention
Clinical Assistant Professor of Medicine
NYU Medical School and NYU Center for Cardiovascular
Prevention
Director, Bellevue Hospital Lipid Clinic
Past President, Northeast Chapter National Lipid
Association
New York, NY
Past President, American Society of Endocrine
Physician Assistants
Adjunct Clinical Professor, Physician Assistant Program
James Madison University
Clinical Instructor, Physician Assistant Program
George Washington University
Diabetes and Thyroid Associates
Fredericksburg, VA
Willy Valencia, MD
GRECC Physician
Geriatric Medicine / Endocrinology
Diabetes & Metabolism
Associate Director
Geriatric Medicine Fellowship Program
Voluntary Assistant Professor
Division of Epidemiology
Miami Veteran Affairs Healthcare System
Miami, FL
Co-Director, Lipid Clinic
UCLA Medical Center
Los Angeles, CA
Whitney Woodmansee, MD
Director, Clinical Neuroendocrine Program
Division of Endocrinology, Diabetes and Hypertension
Boston, MA
PRI-MED SOUTH
25
FINANCIAL DISCLOSURES
Not available at time of printing.
Katherine Galluzzi, DO, CMD,
FACOFP dist.
No financial relationships to disclose.
Faculty
M. Susan Burke, FACP, MD
Speaking honoraria from Merck and Co, Inc.
Receives grant/research support from Abbott,
AstraZeneca, Cephalon, Inc., Cleveland
Foundation, Department of Defense, Eli Lilly
and Company, GlaxoSmithKline, Health
Resources Services Administration, H.
Lundbeck A/S, National Alliance for Research
on Schizophrenia and Depression (NARSAD),
National Institutes of Mental Health (NIMH)
and Stanley Medical Research Institute. He
receives honoraria for his role as a consultant
to Biomedical Development Corp., Convergent
Health Solutions, LLC, Dainippon Sumitomo
Pharma Co., Ltd., Élan Corporation plc, Forest
Laboratories, Inc., GlaxoSmithKline, Health &
Wellness Partners of New Jersey, LLC, F.
Hoffmann-La Roche Ltd, Eli Lilly and Company,
H. Lundbeck A/S, Otsuka Pharmaceutical Co.,
Ltd., Pfizer Inc., Sunovion Pharmaceuticals Inc.,
Takeda Pharmaceutical Company Limited, and
Web ID. He also receives honoraria for his role
as a speaker from AstraZeneca, Benecke CME,
Dainippon Sumitomo Pharma Co., Ltd., Élan
Corporation plc, Forest Laboratories, Inc.,
GlaxoSmithKline, Health & Wellness Partners of
New Jersey, LLC, H. Lundbeck A/S, Medwiz
Healthcare Communication Pvt. Ltd., Otsuka
Pharmaceutical Co., Ltd., ProMedica,
ScientiaCME, LLC., Spirant Communication Pvt.
Ltd., Sunovion Pharmaceuticals Inc., Takeda
Pharmaceutical Company Limited, and Teva
Pharmaceutical Industries, Ltd.
Brooks D. Cash, MD, AGAF, FACG,
FACP, FASGE
Receives consulting fees for Zx Pharma. Is on
the Speakers Bureau for Forest Laboratories,
Inc.; Ironwood Pharmaceuticals; Salix
Pharmaceuticals, Inc.; Takeda Pharmaceutical
Company Ltd; Medical Advisory Board for
Forest Laboratories, Inc.; Ironwood
Pharmaceuticals; PAION AG; Salix
Pharmaceuticals, Inc.; Takeda Pharmaceutical
Company Ltd.
Jessica Castle, MD
26
PRI-MED SOUTH
Receives honoraria for his role as a consultant
to Forest Laboratories, Inc., Halio Health, Merck
& Co., Inc., Otsuka Pharmaceutical Co., Ltd.,
Pamlab, Inc., Sunovion Pharmaceuticals Inc.,
and Takeda Pharmaceutical Company Limited.
He also receives honoraria for his role as a
speaker from Forest Laboratories, Inc., Merck &
Co., Inc., Otsuka Pharmaceutical Co., Ltd.,
Pamlab, Inc., Sunovion Pharmaceuticals Inc.,
and Takeda Pharmaceutical Company Limited.
He also holds equity in Halio Health.
Is on the Medical Advisory Board for Forest
Laboratories, Inc.; Furiex Pharmaceuticals, Inc.;
Ironwood Pharmaceuticals; Salix
Receives consulting fees from Amarin.
John Russell, MD
Receives promotional honorarium from Sanofi
Pasteur for speaking and teaching.
Annual Conference Faculty
Maria Abreu, MD
Receives consulting fees for AbbVie
Laboratories, Prometheus Labs, Sanofi Aventi,
Takeda Pharmaceutical Company Ltd., UCB,
Pfizer, Janssen, Mucosal Health Board, GSK
Holding Americas, Inc., Hospira Inc., Shire
Pharmaceuticals, Salix Pharmaceuticals, Ltd.,
Ferring Pharmaceuticals. Serves on the
Scientific Advisory Board for Asana Medical Inc.
Speakers Bureau for Allergan, Inc., Depomed,
Inc., Janssen Pharmaceuticals, Inc., Millennium
Laboratories, LLC, and XenoPort, Inc.; Advisory
Board member for Acorda Therapeutics, Inc.,
AstraZeneca Pharmaceuticals LP, Depomed,
Inc., Insys Therapeutics Inc., Nektar
Therapeutics, Pfizer Inc., Purdue Pharma L.P.,
QRX Pharma Ltd., Teva Pharmaceuticals
Industries Ltd., and XenoPort, Inc.; Receives
research support from Eli Lilly and Company,
Endo Pharmaceuticals Inc., and Forest
Laboratories, Inc.
Neal Barnard, MD
Donna H. Ryan, MD
Neil Skolnik, MD
Receives the following: consulting fee,
promotional honoraria for speaking and
teaching, and is a member on the advisory
committee for AstraZeneca.
Laurence Sperling, MD, FACC,
FACP, FAHA
Has no relevant financial relationship to report.
Primary Care Updates Planning and
Review Disclosures
Nonfaculty contributors to planning, content
development, and editing and review of
content for Primary Care Updates representing
pmiCME (including staff, advisory boards,
consultants, and contractors); the American
College of Physicians; Horizon CME; Institute
for Medical and Nursing Education; Integritas
Communications Group; Medtelligence, LLC;
Miller Medical Communications, LLC; Vindico
Medical Education, LLC; and Tufts Healthcare
Institute have nothing to disclose.
Consultant for AstraZeneca, Bristol-Myers
Squibb, Eisai Inc, GlaxoSmithKline, Janssen
Pharmaceuticals, Inc., Merck & Co., Inc, Novo
Nordisk, Quest Diagnostics, and sanofi-aventis.
His institution, Ochsner Clinic Foundation,
received grant/research support from Eli Lilly
and Company, Novo Nordisk, and Sanofi. He is
a member of the speakers’ bureaus for Amylin
Pharmaceuticals, Inc., AstraZeneca, BristolMyers Squibb, Eisai Inc, GlaxoSmithKline,
Janssen Pharmaceuticals Inc, Merck & Co., Inc.,
Novo Nordisk, Quest Diagnostics, and Sanofi.
Is a member of the Speakers’ bureaus for Lilly,
Novo Nordisk, Sanofi, Medtronic, Merck,
Janssen, and AstraZeneca. He serves on the
medical advisory board for Novo Nordisk,
Sanofi, Medtronic, and Janssen. He does
contracted research for Novo Nordisk, Sanofi,
Medtronic, Mankind, and NIH.
FINANCIAL DISCLOSURES
Michael J. Brennan, MD,
FACP, FASAM
Advisory board member for Insys Therapeutics
Inc., Mallinckrodt Pharmaceuticals, Purdue
Pharma L.P., Teva Pharmaceuticals Industries
Ltd., and Zogenix, Inc.
Marilyn K. Glassberg, MD
Erin N. Marcus, MD, MPH
Steering Committee, PIPF-016 InterMune Lead
Investigator, Nintedanib EAP, Boehringer
Ingelheim.
Gregory Brent, MD
Jeffrey Gudin, MD
Dean Ornish, MD
Speakers Bureau for Endo Pharmaceuticals,
Covidien, Nektar, Pfizer, and Purdue. Consultant
for Alere and Shionogi.
Consulting fees from Boehringer Ingelheim
GmbH and Melinta Therapeutics. She and her
spouse hold an ownership interest in Sarepta
Therapeutics, Inc.; Seattle Genetics; Antares
Pharma, Inc.; and Novartis. Spouse is employed
by Novartis Corporation.
Janet Pregler, MD, FACP
Culley Carson, MD
Auxilium: consultant and speaker, AbbVie:
Consultant; AMS: consultant and speaker.
Contracted Clinical Research for Otsuka
Pharmaceutical and Toyama Chemical Co.
Nestor de la Cruz-Munoz, MD,
FACS, FASMBS
James V. Hennessey, MD, FACP
Receives speaking and consulting fees from
St. Jude Medical, Cardio MEMS, Novartis, and
Relypsa. Medical Advisory Board for Relypsa
and part of the clinical trial leadership for
Novartis.
Frank Domino, MD
Speakers Bureau for Amgen, Genentech, Pfizer,
BMS, Takeda, and AbbVie.
Daiichi Sankyo: investigator, consultant, and
Advisory Board; Boehringer Ingelheim:
consultant and Advisory Board.
Advisory Committee, stock ownership, and
speaker for Gilead, BMS, AbbVie, and Merck.
Ciaran P. Kelly, MD
Janine Sanchez, MD
Grant support as an investigator for Plympus
Cook Medical and Cosmo Pharma, CDX labs.
Consultant to AMS, Auxilium, and Coloplast.
Akshay Desai, MD, MPH
Robert H. Hopkins, Jr., MD,
FACP, FAAP
Michael Curry, MD
Sammy Saab, MD, MPH, AGAF
Thomas K. Cummins, MD
Ki Park, MD
Receives consulting fees from Coloplast,
American Medical Systems and Auxilium.
Dr. Kohler is an independent contractor
for Abbvie.
James A. Underberg, MD, MS,
Speakers’ bureaus for Sanofi, Merck, Kowa,
Genzyme, AstraZeneca, Liposcience. He is on the
Medical Advisory Boards for Novartis, Amgen,
AstraZeneca, Aegerion, and Sanofi. He receives
consulting fees from Liposcience and Amgen,
and research fees from Aegerion and Kowa.
Walter Lambert, MD
Willy Valencia, MD
Serves as an unpaid consultant to Amgen;
AstraZeneca; Boehringer Ingelheim; BristolMyers Squibb; Esperion Therapeutics;
Genzyme; GlaxoSmithKline; Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation; Pfizer
Inc.; and Sanofi-Regeneron. He also serves on
the Scientific Advisory Board for Athera
biotechnologies and Interleukin Genetics.
Dr Libby’s laboratory receives research funding
from General Electric, GlaxoSmithKline and
Novartis Pharmaceuticals Corporation.
Merck clinical trials adjudicator.
Whitney Woodmansee, MD
Annual Meeting Planning and
Review Disclosures
Nonfaculty contributors to planning, content
development, and editing and review of
content for the annual meeting representing
pmiCME (including staff, advisory boards,
consultants, and contractors), American
College of Physicians, and Tufts Healthcare
Institute have nothing to disclose.
PRI-MED SOUTH
27
EXHIBITORS BY ALPHABETICAL LISTING
A Fashion Hayvin, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1105
Actavis (formerly Forest Pharmaceuticals, Inc.). . . . . . . 223
www.actavis.com
AllergiEnd. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
www.allergiend.com
Allergy Free Labs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 925
www.allergyfreelabs.com
Alzheimers Association . . . . . . . . . . . . . . . . . . . . . . . . . . . 1010
Amarin Pharma, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
AmazingCharts. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 815
www.amazingcharts.com
American College of Physicians. . . . . . . . . . . . . . . . . . . . . 523
American Express . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1003
AMGEN. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 714
AspirinWorks by Corgenix. . . . . . . . . . . . . . . . . . . . . . . . . . 200
www.aspirinworks.com
AstraZeneca . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 422
ATS Healthcare. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 826
www.atshealth.com/contactus.html
Auxilium Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . 1025
www.Auxilium.com
Bankers Healthcare Group, Inc.. . . . . . . . . . . . . . . . . . . . . . 211
www.bhg-inc.com
Behavioral Health of The Palm Beaches . . . . . . . . . . . . . 722
www.bhpalmbeach.com
Bionix Medical Technologies. . . . . . . . . . . . . . . . . . . . . . . 210
www.BionixMED.com
Boehringer Ingelheim Pharmaceuticals, Inc.. . . . . . . . . 803
http://us.boehringer-ingelheim.com
Boiron. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
www.boironusa.com
Bristol-Myers Squibb & Pfizer Inc.. . . . . . . . . . . . . . . . . . 1009
www.pfizer.com
Calmoseptine. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 822
www.calmoseptineointment.com
Cargill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 510
www.cargill.com
Carlson Laboratories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 402
www.carlsonlabs.com
CME Corner / MCM Education. . . . . . . . . . . . . . . . . . . . . . 122
www.cmecorner.com
Concentra Primary Care. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
www.concentra.com
CryoProbe . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 905
Daiichi Sankyo, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1125
www.daiichisankyo.com
28
PRI-MED SOUTH
Dermalogix Partners Inc . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
www.dermalogix.com
Diva International . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
http://divacup.com
eH4H LLC. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
http://eh4h.com
Eisai, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 705
www.eisai.com
Elite Health. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 222
www.elitehealth.com
Elite Medical Scribes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 308
www.elitemedicalscribes.com
Ellman International, LLC. . . . . . . . . . . . . . . . . . . . . . . . . . 1109
www.ellman.com
Elsevier Medical Books. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 403
www.elsevier.com
Empire City Laboratories. . . . . . . . . . . . . . . . . . . . . . . . . . . 1115
http://empirecitylabs.com
Enovative Technologies. . . . . . . . . . . . . . . . . . . . . . . . . . . 1201
www.enovativetech.com
EZBillNow. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
www.ezbillnow.com
Florida Center for Allergy & Asthma Care. . . . . . . . . . . . 107
www.florida-allergy.com
Florida Hospital Heartland Medical Center . . . . . . . . . . 1116
www.floridahospital.com/heartland
Forest Pharmaceuticals (Please see Actavis listing). . . . 223
Fotona LLC. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1210
www.fotona.com
Galderma Laboratories LP. . . . . . . . . . . . . . . . . . . . . . . . . . 923
Genova Diagnostics, Inc . . . . . . . . . . . . . . . . . . . . . . . . . . . 627
www.gdx.net
Gensco Laboratories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1110
www.genscolabs.com
Gilead Sciences. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201
www.gilead.com
GlaxoSmithKline. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 303
www.gsk.com
Grifols USA, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1004
www.grifolsusa.com
Healthcare Clinic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 622
Hemosure. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
www.hemosure.com
I.C. E., Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1102
http://infinitetherapeutics.com/
Impeto Medical, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1108
www.sudoscan.com
Integrity Rehab Group. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 727
http://irg.net/
Janssen Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . . . . 215
EXHIBITORS BY ALPHABETICAL LISTING
JSA Medical Group . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 527
www.jsahealthcare.com
Kareo. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 623
www.kareo.com
KLS DNA, LLC. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 209
Laclede Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 824
www.laclede.com
Life Extension. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1118
www.lef.org
Lippincott Williams & Wilkins. . . . . . . . . . . . . . . . . . . . . . . 101
LocumTenens.com. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1022
http://LocumTenens.com
Maico Diagnostics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 206
Matrix Medical Network. . . . . . . . . . . . . . . . . . . . . . . . . . .1000
www.matrixforme.com
Medical Practice Partners . . . . . . . . . . . . . . . . . . . . . . . . . . 624
http://medicalpracticepartner.com/
MediTouch EHR / HealthFusion. . . . . . . . . . . . . . . . . . . . . . 911
www.healthfusion.com
Merck. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 614
www.merck.com
Micro Direct, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 508
www.micro-direct.com
Mission Pharmacal Co. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 502
www.missionpharmacal.com/
Monthly Prescribing Reference. . . . . . . . . . . . . . . . . . . . . 124
Navajo Area Indian Health Services. . . . . . . . . . . . . . . . 1226
www.ihs.gov/navajo/
Neilmed Pharmaceuticals, Inc.. . . . . . . . . . . . . . . . . . . . . . 901
www.neilmed.com
New Balance Athletic Shoes/Aravon Shoes. . . . . . . . . . 100
www.newbalance.com
Noven Pharmaceuticals Inc. . . . . . . . . . . . . . . . . . . . . . . . . . 118
www.noven.com
Novo Nordisk Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 505
www.novonordisk-us.com
Nutramax Laboratories, Inc.. . . . . . . . . . . . . . . . . . . . . . . . 405
www.nutramaxlabs.com
Orasure Technologies, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . 309
www.orasure.com
Otto Trading, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1101
www.irestmassager.com
Pfizer Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 922
www.pfizer.com
PractRx. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 226
Premier Medical Products. . . . . . . . . . . . . . . . . . . . . . . . . 1222
www.premusa.com
Prestium Pharma, Inc . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1111
www.prestiumpharma.com/
Pri-Med. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 915
Pri-Med InLight. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 914
www.inlightehr.com
Pri-Med Recharge Lounge . . . . . . . . . . . . . . . . . . . . . . . . 1015
Procter & Gamble. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1012
www.pg.com
Qiagen, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
www.qiagen.com
Rome Foundation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 723
www.theromefoundation.org
Salix Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . . . . . 1024
www.salix.com
Shader Productions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1100
www.rockmecz.com
Shire U.S. Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103, 1001
www.shire.com
Smart for Life. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
www.straightmeds.com
Soteria Medical, LLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1224
Summit Doppler Systems. . . . . . . . . . . . . . . . . . . . . . . . . . 724
www.summitdoppler.com
Take Shape for Life . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
www.alisonorlando.tsfl.com
Takeda Pharmaceuticals U.S.A. Inc.. . . . . . . . . . . . . . . . . . 415
www.takeda.us
Televox Software, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 927
www.televox.com
The Gideons International. . . . . . . . . . . . . . . . . . . . . . . . . 1103
www.gideons.org
Tobacco Free Florida. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 310
www.tobaccofreeflorida.com
UCSF / Clinicians Consultation Center. . . . . . . . . . . . . . . 725
www.ucsf.edu/hivcntr/
Ultimate Creations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1203
www.infinitealoe.com
UltraScope. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1123
US Army Medicine Civilian Corps . . . . . . . . . . . . . . . . . . . 626
www.civilianmedicaljobs.com/
VitalMD Group Holding, LLC. . . . . . . . . . . . . . . . . . . . . . . . 202
www.vitalmd.com
Vitamix. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1200
www.vitamix.com
Wexford Health Sources . . . . . . . . . . . . . . . . . . . . . . . . . . . . 311
www.wexfordhealth.com
WynnPharm Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 404
www.wynnpharm.com
Xenna Corp . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1002
www.xenna.com
Zanfel Laboratories, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1011
www.zanfel.com
PRI-MED SOUTH
29
EXHIBITORS BY PRODUCT CATEGORY
Orasure Technologies, Inc. . . . . . . . . . . . . . . 309
Qiagen, Inc. . . . . . . . . . . . . . . . . . . . . . . . .125
Soteria Medical, LLC . . . . . . . . . . . . . . . . . . 1224
Academia, Associations or Nonprofit
Organizations
Alzheimers Association . . . . . . . . . . . . . . . 1010
American College of Physicians . . . . . . . . . . . 523
Rome Foundation . . . . . . . . . . . . . . . . . . . 723
Tobacco Free Florida . . . . . . . . . . . . . . . . . . 310
Career, Recruitment & Clinician Network
LocumTenens.com . . . . . . . . . . . . . . . . . . . 1022
US Army Medicine Civilian Corps . . . . . . . . . . 626
Consumer Products & Services
A Fashion Hayvin, Inc. . . . . . . . . . . . . . . . . . 1105
Enovative Technologies . . . . . . . . . . . . . . . 1201
I.C. E., Inc. . . . . . . . . . . . . . . . . . . . . . . . . 1102
New Balance Athletic Shoes/Aravon Shoes . . . . 100
Otto Trading, Inc. . . . . . . . . . . . . . . . . . . . 1101
Shader Productions . . . . . . . . . . . . . . . . . . 1100
The Gideons International . . . . . . . . . . . . . . 1103
Ultimate Creations . . . . . . . . . . . . . . . . . . . 1203
Vitamix . . . . . . . . . . . . . . . . . . . . . . . . . . 1200
Dermatology
Calmoseptine . . . . . . . . . . . . . . . . . . . . . . 822
Dermalogix Partners Inc . . . . . . . . . . . . . . . . 110
Prestium Pharma, Inc . . . . . . . . . . . . . . . . . 1111
Zanfel Laboratories, Inc. . . . . . . . . . . . . . . . 1011
Diagnostics, Laboratories & Testing
AllergiEnd . . . . . . . . . . . . . . . . . . . . . . . . .126
AspirinWorks by Corgenix . . . . . . . . . . . . . . 200
Empire City Laboratories . . . . . . . . . . . . . . . 1115
KLS DNA, LLC . . . . . . . . . . . . . . . . . . . . . . 209
Allergy Free Labs . . . . . . . . . . . . . . . . . . . . 925
Florida Center for Allergy & Asthma Care . . . . . 107
Genova Diagnostics, Inc . . . . . . . . . . . . . . . . 627
Hemosure . . . . . . . . . . . . . . . . . . . . . . . . 106
30
PRI-MED SOUTH
UltraScope . . . . . . . . . . . . . . . . . . . . . . . . 1123
Education
CME Corner / MCM Education . . . . . . . . . . . . .122
UCSF / Clinicians Consultation Center . . . . . . . 725
Financial Services
American Express . . . . . . . . . . . . . . . . . . . 1003
ATS Healthcare . . . . . . . . . . . . . . . . . . . . . 826
Bankers Healthcare Group, Inc. . . . . . . . . . . . .211
Healthcare Network or Provider
Behavioral Health of The Palm Beaches . . . . . . 722
Concentra Primary Care . . . . . . . . . . . . . . . . 114
Elite Health . . . . . . . . . . . . . . . . . . . . . . . . 222
Florida Hospital Heartland Medical Center . . . . 1116
Integrity Rehab Group . . . . . . . . . . . . . . . . . 727
JSA Medical Group . . . . . . . . . . . . . . . . . . . 527
Matrix Medical Network . . . . . . . . . . . . . . . 1000
Navajo Area Indian Health Services . . . . . . . . 1226
Medical Device
Bionix Medical Technologies . . . . . . . . . . . . . 210
CryoProbe . . . . . . . . . . . . . . . . . . . . . . . . 905
Diva International . . . . . . . . . . . . . . . . . . . .123
eH4H LLC . . . . . . . . . . . . . . . . . . . . . . . . . 112
Ellman International, LLC . . . . . . . . . . . . . . . 1109
Fotona LLC . . . . . . . . . . . . . . . . . . . . . . . 1210
Impeto Medical, Inc. . . . . . . . . . . . . . . . . . . 1108
Maico Diagnostics . . . . . . . . . . . . . . . . . . . 206
Micro Direct, Inc. . . . . . . . . . . . . . . . . . . . . 508
Summit Doppler Systems . . . . . . . . . . . . . . . 724
Medical Supplies & Equipment
Laclede Inc . . . . . . . . . . . . . . . . . . . . . . . . 824
Premier Medical Products . . . . . . . . . . . . . . 1222
EXHIBITORS BY PRODUCT CATEGORY
Miscellaneous
Elite Medical Scribes . . . . . . . . . . . . . . . . . . 308
Pri-Med . . . . . . . . . . . . . . . . . . . . . . . . . . 915
Pri-Med Recharge Lounge . . . . . . . . . . . . . . 1015
Nutrition & Wellness
Cargill . . . . . . . . . . . . . . . . . . . . . . . . . . . 510
Carlson Laboratories . . . . . . . . . . . . . . . . . . 402
Life Extension . . . . . . . . . . . . . . . . . . . . . . 1118
Nutramax Laboratories, Inc. . . . . . . . . . . . . . 405
Smart for Life . . . . . . . . . . . . . . . . . . . . . . 105
Take Shape for Life . . . . . . . . . . . . . . . . . . . . 111
WynnPharm Inc. . . . . . . . . . . . . . . . . . . . . 404
OTC Medicine and Treatment
Boiron . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
Neilmed Pharmaceuticals, Inc. . . . . . . . . . . . . 901
Xenna Corp . . . . . . . . . . . . . . . . . . . . . . . 1002
Pharmaceutical
Actavis (formerly Forest Pharmaceuticals, Inc.) . . 223
Amarin Pharma, Inc. . . . . . . . . . . . . . . . . . . . 117
AMGEN . . . . . . . . . . . . . . . . . . . . . . . . . . .714
AstraZeneca . . . . . . . . . . . . . . . . . . . . . . . 422
Auxilium Pharmaceuticals, Inc. . . . . . . . . . . . 1025
Boehringer Ingelheim Pharmaceuticals, Inc. . . . 803
Bristol-Myers Squibb & Pfizer Inc. . . . . . . . . . .1009
Daiichi Sankyo, Inc. . . . . . . . . . . . . . . . . . . 1125
Eisai, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . 705
Galderma Laboratories LP . . . . . . . . . . . . . . 923
Gensco Laboratories . . . . . . . . . . . . . . . . . 1110
Gilead Sciences . . . . . . . . . . . . . . . . . . . . . 201
GlaxoSmithKline . . . . . . . . . . . . . . . . . . . . 303
Grifols USA, Inc. . . . . . . . . . . . . . . . . . . . . 1004
Noven Pharmaceuticals Inc . . . . . . . . . . . . . . 118
Novo Nordisk Inc. . . . . . . . . . . . . . . . . . . . . 505
Janssen Pharmaceuticals, Inc . . . . . . . . . . . . . 215
Merck . . . . . . . . . . . . . . . . . . . . . . . . . . . .614
Mission Pharmacal Co . . . . . . . . . . . . . . . . . 502
Pfizer Inc. . . . . . . . . . . . . . . . . . . . . . . . . . 922
Procter & Gamble . . . . . . . . . . . . . . . . . . . 1012
Salix Pharmaceuticals, Inc. . . . . . . . . . . . . . . 1024
Shire U.S. Inc. . . . . . . . . . . . . . . . . . . . 103, 1001
Takeda Pharmaceuticals U.S.A. Inc. . . . . . . . . . .415
Pharmacy
Healthcare Clinic . . . . . . . . . . . . . . . . . . . . 622
Practice Management
AmazingCharts . . . . . . . . . . . . . . . . . . . . . .815
EZBillNow . . . . . . . . . . . . . . . . . . . . . . . . 108
Kareo . . . . . . . . . . . . . . . . . . . . . . . . . . . 623
Medical Practice Partners . . . . . . . . . . . . . . . 624
MediTouch EHR / HealthFusion . . . . . . . . . . . .911
PractRx . . . . . . . . . . . . . . . . . . . . . . . . . . 226
Pri-Med InLight . . . . . . . . . . . . . . . . . . . . . .914
Televox Software, Inc. . . . . . . . . . . . . . . . . . 927
VitalMD Group Holding, LLC . . . . . . . . . . . . . 202
Wexford Health Sources . . . . . . . . . . . . . . . . 311
Publishing
Elsevier Medical Books . . . . . . . . . . . . . . . . 403
Lippincott Williams & Wilkins . . . . . . . . . . . . .101
Monthly Prescribing Reference . . . . . . . . . . . .124
PRI-MED SOUTH
31
CONVENTION CENTER MAPS
Exhibit Halls A-C
32
PRI-MED SOUTH
BROWARD COUNTY CONVENTION CENTER
PRI-MED SOUTH
33
CONVENTION CENTER MAPS
Level 2
34
PRI-MED SOUTH
Level 3
Clinicians Love
Amazing Charts
#1 Rated EHR
for Usability
in 2014
“ Unlike other EHRs, Amazing Charts actually lets me have more
face-to-face time with patients.”
– Dr. James Legan
“I felt comfortable switching from our former EHR to Amazing Charts.
They were very responsive to any issues we had during our transition.”
– Dr. Vishal Datta
“ Amazing Charts is so easy to use we actually get home in time for dinner.
Our kids can’t believe it!”
– Drs. Jennifer and David Benson
Start your FREE trial at booth #815
866-382-5932
[email protected]
www.amazingcharts.com
THE EHR THAT’S
PROBLEM-ORIENTED
SO YOU CAN BE
PEOPLE-ORIENTED
Visit booth #914 for a demo of the newest
concept in EHRs from the team at
Amazing Charts and Pri-Med.
FREE 60-day trials
now available.
1-844-899-4448 | [email protected]
www.inlightehr.com

Onsite Guide - Pri-Med

Transcription

Similar documents

classes for all ages : first course spring term

Allegro Invational

2016 SFOpen Dance Camp

Contra dance - Maple Leafs Regroup

Sounds of the Early Seventies: “Desperado” and “Ballroom Blitz”

McElroy`s Ballroom: Home of Portland`s Happy Feet

June 2016 - Sri Atmananda Memorial School

Milt Glick Grand Ballrooms

Worldwide Local Flyer yb 7